MedTrace Logo

Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study)

NCT00377468 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2008-06-30

No results posted yet for this study

Summary

The purpose of this study is to determine whether application of low dose Delta9-Tetrahydrocannabinol can prevent the development of chronic pain in patients with acute CRPS.

Conditions

  • Complex Regional Pain Syndromes
  • CRPS

Interventions

DRUG

Delta9-Tetrahydrocannabinol

Sponsors & Collaborators

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV

  • German Research Network on Neuropathic Pain

    collaborator NETWORK

  • Ludwig-Maximilians - University of Munich

    lead OTHER

Principal Investigators

  • Shahnaz C Azad, MD;PhD · Department of Anesthesiology, Interdisciplinary Pain Clinic Grosshadern, University of Munich

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Completion
2008-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00377468 on ClinicalTrials.gov